- Open Access
Bone mineral density and content during weight cycling in female rats: effects of dietary amylase-resistant starch
Nutrition & Metabolism volume 5, Article number: 34 (2008)
Although there is considerable evidence for a loss of bone mass with weight loss, the few human studies on the relationship between weight cycling and bone mass or density have differing results. Further, very few studies assessed the role of dietary composition on bone mass during weight cycling. The primary objective of this study was to determine if a diet high in amylase-resistant starch (RS2), which has been shown to increase absorption and balance of dietary minerals, can prevent or reduce loss of bone mass during weight cycling.
Female Sprague-Dawley (SD) rats (n = 84, age = 20 weeks) were randomly assigned to one of 6 treatment groups with 14 rats per group using a 2 × 3 experimental design with 2 diets and 3 weight cycling protocols. Rats were fed calcium-deficient diets without RS2 (controls) or diets high in RS2 (18% by weight) throughout the 21-week study. The weight cycling protocols were weight maintenance/gain with no weight cycling, 1 round of weight cycling, or 2 rounds of weight cycling. After the rats were euthanized bone mineral density (BMD) and bone mineral content (BMC) of femur were measured by dual energy X-ray absorptiometry, and concentrations of calcium, copper, iron, magnesium, manganese, and zinc in femur and lumbar vertebrae were determined by atomic absorption spectrophotometry.
Rats undergoing weight cycling had lower femur BMC (p < 0.05) and marginally lower BMD (p = 0.09) than rats not undergoing weight cycling. In comparison to controls, rats fed RS2 had higher femur BMD (p < 0.01) and BMC (p < 0.05), as well as higher values for BMD and BMC measured at the distal end (p < 0.001 and p < 0.01) and femoral neck (p < 0.01 and p < 0.05). Consistent with these findings, RS2-fed rats also had higher femur calcium (p < 0.05) and magnesium (p < 0.0001) concentrations. They also had higher lumbar vertebrae calcium (p < 0.05) and magnesium (p < 0.05) concentrations.
Weight cycling reduces bone mass. A diet high in RS2 can minimize loss of bone mass during weight cycling and may increase bone mass in the absence of weight cycling.
Although obesity has a number of well-documented adverse effects on health, obese men and women have higher bone mineral density (BMD) and bone mineral content (BMC) than their age and gender-matched counterparts with lower body weights . Weight cycling is the repeated loss and regain of body weight, and occurs frequently in obese and overweight men and women in their attempts to lose weight and maintain a lower body weight. Weight cycling may also occur in men and women of normal body weight or in those with eating disorders such as anorexia nervosa. The goal of intentional weight loss is to reduce fat mass, but there is typically an accompanying unwanted loss of lean body mass, including bone mass . Although there is convincing evidence for a loss of bone mass with weight loss , there are only a few human studies on the relationship between weight cycling and bone mass or density. A small number of epidemiologic studies demonstrate that a history of weight cycling is associated with a reduction in bone mineral density or an increased risk of hip and other fractures in men and women [2–5]. In one of these studies , greater weight variability in a sample of about 20,000 women and 19,000 men was associated with relative risks of hip fracture of 2.07 for women and 2.70 for men. In another study of 169 premenopausal women , weight cycling was associated with significant (p < 0.01) decreases in BMD at the lumbar spine and distal radius. In the above studies, the significant relationships between weight cycling and hip fracture or BMD persisted even after correction for body weight. In more recent studies, Sogaard et al.  found that weight cycling in elderly Norwegian men was a risk factor for forearm fracture, and Bacon et al.  reported that chronic dieting in 30–45 year old obese women was associated with low bone mass. In contrast other investigators found that weight cycling did not reduce bone mass in competitive athletes  and overweight, sedentary, premenopausal women . The varying results of the above and other human studies on the relationship between weight cycling and bone mass may be due to the many factors that cannot be adequately controlled in human studies, including subject diets, compliance with the study protocol, and patterns of weight loss. Furthermore, a history of weight cycling may define a subgroup of people at risk for bone loss due to other factors.
It is not known if dietary composition during weight cycling can influence bone mass, quality, and strength; specific diet components that may influence bone during weight cycling include vitamins D and K, calcium, magnesium, several essential trace minerals, and the resistant starches. Resistant starches (RS1, RS2, RS3, RS4 and RS5) are subgroups of fiber that occur naturally in foods or can be produced during food processing [8–11]. Total resistant starch is estimated to be about 10% (range = 2–20%) of ingested starches in Western diets . The resistant starches are not digested by mammalian enzymes in the mouth, stomach, or small intestine, but may be fermented in the colon [8–11]. Categorization of the five types of resistant starch is based on the factors that explain their resistance to degradation in the upper gastrointestinal tract. These factors include physical entrapment of the starch by the native cellular structure (RS1), the physical structure of the starch granules (RS2), or their chemical composition (RS3, RS4, and RS5) (8–10). RS2 is the subtype most widely used commercially. We selected it for this investigation because a number of prior studies from other laboratories provide considerable evidence demonstrating that dietary RS2 improves absorption and balance of calcium, magnesium, and several trace minerals in experimental animals, particularly the rat [12–19]. This study is based on the hypothesis that RS2, by reducing gastrointestinal loss of calcium, magnesium, and other bone minerals, may help to maintain bone mass subsequent to weight cycling.
Because of the difficulty of controlling the various factors that could influence the effects of weight cycling on bone mass in humans, we conducted a study in rats so that diet composition, weight cycling patterns, age, and other relevant variables could be tightly controlled. The primary objective of this investigation was to determine if a diet high in natural RS2 from high-amylose cornstarch (also termed "maize starch") can reduce or prevent loss of femur BMD and BMC subsequent to weight cycling in female rats. The female Sprague-Dawley (SD) rat was chosen as the experimental model based on prior studies in our laboratories in this species; these studies suggest that the female SD rat is an appropriate model for the study of relationships between weight loss and bone composition [20–24]. A second goal was to analyze bone for other minerals and trace elements that are known or suspected to be required for optimal bone strength, specifically calcium, copper, iron, magnesium, manganese, and zinc . This was done to obtain insight into specific bone metals that may be involved in the effects of weight cycling and/or dietary resistant starch on bone. A third goal was to analyze selected non-calcified organs (liver and kidney) with high metabolic activity for the same metals in order to compare effects of weight cycling and dietary resistant starch on bone versus soft tissue minerals.
Diets were formulated and prepared by Research Diets, Inc., New Brunswick, NJ. The composition of these diets is described in Table 1. Carbohydrate in each diet is provided by waxy cornstarch, pregelatinized waxy cornstarch, and sucrose. A mixture of waxy cornstarch, pregelatinized waxy cornstarch, and sucrose was used for the control (normal) diets to provide a resistant-starch-free formulation capable of being formed into pellets. For the diets containing resistant starch, Hi-maize 260® starch (National Starch and Chemical Company, Bridgewater, NJ) was substituted for a portion of the waxy cornstarch (Amioca, 0% amylose). Hi-maize 260 starch, a hydrothermally-treated RS2 starch composed of 60% total dietary fiber as RS2-type granules, is derived from cornstarch high in amylose but is resistant to enzymatic degradation by amylase. A target of 18–20% by weight of Hi-maize 260 starch was chosen because diets with a similar concentration of this component have been shown to improve retention of calcium, magnesium, and some trace minerals in the rat .
The study was designed to ensure comparable dietary intake in all treatment groups during weight gain or weight loss of calcium, phosphorus, magnesium, and each of the essential vitamins and trace minerals. To achieve this goal, 4 diet formulations were required, as described in Table 1. The diets were formed into cylindrical pellets (22 mm × 12 mm in diameter) and colored with FD&C dyes to provide a distinct color for each diet formulation and facilitate conduct of the study by allowing easy identification of each of the four diets. Diet NDWL (normal diet for weight loss) was formulated to have concentrations of AIN-76 salt mix, calcium phosphate, AIN-76A vitamin mix, and choline bitartrate that were 40% higher than Diet ND (normal ad lib diet). Similarly, Diet RSWL (resistant starch (RS2) weight loss diet) was formulated to have concentrations of AIN-76 salt mix, calcium phosphate, AIN-76A vitamin mix, and choline bitartrate that were 40% higher than Diet RS (resistant starch (RS2) ad lib diet). Diets ND and RS were fed except when rats were undergoing energy restriction to achieve weight loss; during energy restriction diets NDWL or RSWL were fed.
The target calcium concentration for Diets ND and RS was 1.0 mg of calcium per gram of diet (0.1% calcium by weight = 25 μmol/g), a concentration that is 20% of the calcium concentration of the standard AIN-76 diet, and can be considered to be moderately deficient for the rat. This approach was used because many younger adults and more than 50% of older adults living in the United States, including those who use calcium-containing antacids or supplements, consume diets that are considered to be inadequate in calcium , and thus may be at higher risk of loss of bone mass during weight loss .
Animal care and treatment
Female rats were chosen for this study because low BMD and BMC, as well as a higher risk of osteoporosis and osteoporosis-related fractures, are more common in women than men, and because of our prior experience studying effects of weight loss on bone in women and female rats [20–24].
The number of rats chosen per treatment group (n = 14) exceeds the number per group (as few as 6) in prior studies conducted in our laboratories [20–23] that demonstrate significant loss of bone mass after weight loss. In addition we conducted a power analysis based on the effect of a projected 18% loss of body weight on bone density in the rat. Using conservative assumptions and data from our prior studies, the power analysis showed that with 12 rats per treatment group and alpha = 0.05, there is 90% power to detect a difference in BMD between treatment groups of 4.7% and 80% power to detect a difference of 4.0%. Thus, it was anticipated that 14 rats per group would provide adequate statistical power to detect treatment effects of moderate size on the major outcome variables of BMD and BMC even with attrition of as many as 2 rats per group.
Sexually mature female Sprague-Dawley (SD) rats (Charles River, Raleigh, NC, n = 84, age = 20 weeks) were randomly assigned to one of six treatment groups with 14 rats per group using a 2 × 3 experimental design with 2 diets and 3 weight cycling protocols. Because body weight is strongly associated with bone mass, rats were stratified by body weight prior to random assignment to one of the 6 treatment groups to ensure nearly identical initial mean body weights in each of the 6 groups. As anticipated, this approach to random assignment resulted in very similar mean body weights at randomization (281.2–282.5 g) in each of the six treatment groups (Figure 1). Rats were fed pelleted diets without RS2 (ND = normal diets, controls) or diets high in RS2 (17.9–18.1%) throughout the study. The weight cycling protocols were: weight maintenance with no weight cycling (Groups ND0 and RSD0), 1 round of weight cycling (Groups ND1 and RSD1), or 2 rounds of weight cycling (Groups ND2 and RSD2).
Diets ND or RS were fed upon arrival of the rats in our laboratories for 8 days prior to the initiation of energy restriction/weight loss. The plan and chronology of weight loss and weight regain is illustrated in Figure 1. The timing of the single round of weight cycling for those rats undergoing this treatment coincided with the final (second) round of weight cycling in rats undergoing 2 rounds of weight cycling. Weight loss was achieved by restriction of energy intake to 60% of that of rats in groups fed ad lib, as in our prior studies [20, 21, 23]. All rats were allowed to consume feed ad lib when not undergoing weight loss.
Feed consumption was monitored by weighing all feed provided and subtracting feed not eaten. Feed consumed by rats eating ad lib during a week was used to calculate the reduced amounts of feed provided to rats consuming energy restricted diets during the following week. When rats were consuming diets ad lib, they were fed once per week. When rats were consuming energy restricted diets, they were fed daily including weekends, and invariably ate all feed provided.
Rats were housed throughout the study in individual cages in a separate, locked room in the New Jersey Medical School Research Animal Facility, which is AAALAC accredited. Cages and cage racks were labeled with tape of six different colors to facilitate identification of rats in each of the six treatment groups. No other animals were housed in the room during the study. Blood withdrawal was done in a nearby procedure room within the Research Animal Facility
After completion of the second round of weight regain after 21 weeks, blood was obtained by cardiac puncture under anesthesia with 0.6 ml/100 g of a mixture of ketamine (20 mg/ml) and xylazine (2.5 mg/ml) administered intraperitoneally. Rats were then euthanized by decapitation after administration of additional anesthetic if necessary. Both femurs and the spinal column bones of the lumbar region were harvested. Other organs harvested from each rat were liver and kidney. Procedures used to harvest the organs have been used on many occasions in our laboratory and have been designed to minimize the potential of organ metal contamination during harvesting. For the right femur to be used for measurement of BMD and BMC, femurs were preserved by wetting them with 50% physiological saline (0.42%) solution and wrapping them in cotton gauze saturated with 50% saline prior to freezing. All blood and organ samples were stored at -70°C until analysis.
After placing the excised femur on a Delrin block, BMC and BMD of the right femurs were determined by dual energy x-ray absorptiometry (DEXA) using a GE-Lunar PIXImus densitometer with software version 1.4×. The PIXImus densitometer uses a 14 degree stationary anode X-ray tube generator with a 0.25 mm × 0.25 mm focal spot that generates a cone beam X-ray (55/80 kVp at 400 μA). The right femurs were analyzed for the whole bone "total" BMD and BMC, and at 2 other standard sites prone to fracture, specifically the femoral neck and the distal femur (20% from the distal end of the bone) .
After non-destructive analysis by DEXA, the right femurs were subsequently used for laboratory analyses of their mineral composition; this enabled measurement of mineral concentrations using the same bone that was used to determine BMD and BMC. The right femur and lumbar vertebrae bones were analyzed for minerals and trace elements that are considered to be essential or beneficial for optimal bone strength, specifically calcium, copper, magnesium, manganese, and zinc . Iron was also determined in these samples. For these analyses the entire right femur and a set of 3–4 lower lumbar vertebrae were assayed; the bone samples were cleaned of all non-calcified tissue before analysis. The non-calcified organs collected (kidney and liver) were also analyzed for the same metals. These analyses were conducted using flame or electrothermal atomic absorption spectrophotometry. Standards, blanks, and National Institute of Standards and Technology (NIST, Gaithersburg, MD) Standard Reference Materials (SRM # 1486–Bone Meal or SRM # 1577b–Bovine Liver) with certified values for their metal concentrations were analyzed with each set of daily analyses as a component of our quality control program [20, 21].
Data evaluation methods included descriptive and inferential statistical analyses. Two-way ANOVA was conducted to determine the separate effects of dietary resistant starch and weight cycling, as well as their interactions, on the various study outcome variables. Pairwise differences were evaluated subsequent to 2-way ANOVA by comparison of least-square means at p < 0.05. Associations between selected variables were determined by calculation of Pearson correlation coefficients. A limited number of multiple regression analyses were conducted with BMD or BMC as the dependent variable and final body weight and treatment group as the independent variables.
Ethical treatment of animals
All applicable institutional and governmental regulations concerning the ethical use of animals were followed during this research. The study and its specific procedures were reviewed and approved by the UMDNJ-New Jersey Medical School Institutional Animal Care and Use Committee.
Rats fed the normal diets and their counterparts fed the resistant starch diets had similar total food intakes (mean ± SE) during the 21-week study, specifically 2566 ± 97 g and 2585 ± 88 g for those rats not undergoing weight cycling, 2333 ± 59 g and 2424 ± 53 g for those rats subject to one round of weight cycling, and 2142 ± 31 g and 2118 ± 55 g for those rats undergoing two rounds of weight cycling.
Table 2 contains the results of our analyses of diet concentrations of iron and the 5 metals for which there is evidence that they are essential (Ca) or likely to be important (Cu, Mg, Mn, Zn) in the maintenance of bone mineral density and bone mineral content. Our target for diets moderately deficient in calcium for the rat was a concentration of 1.0 mg of calcium per gram of diet (25.0 μmol/g). Measured mean calcium concentrations for Diets ND and RS fed during periods of weight maintenance or weight gain were 1.09 mg/g (27.2 μmol/g) and 1.07 mg/g (26.7 μmol/g), and thus are within 10% of the target concentration. Calcium present in other food components besides the dibasic calcium phosphate used to add calcium to the diets likely contributed to the total calcium concentration of the diets. Diets NDWL and RSWL that were fed during periods of weight loss at 60% of ad lib were intended to have calcium concentrations that were 40% (1.40-fold) greater than Diets ND and RS; measured values were 51% and 42% greater, respectively. The latter results are based on 8 replicate analyses, but even well mixed solid diets may have some degree of heterogeneity. Measured concentrations of Cu, Fe, Mg, Mn, and Zn in Diets ND and RS were near the target levels for the AIN-76 diet for rodents that are provided in Table 2.
Figure 1 depicts mean body weights for the 14 rats in each of the six treatment groups. These data demonstrate that we were able to successfully produce weight loss and regain in the groups of rats undergoing one round of weight cycling (ND1 and RSD1) or two rounds of weight cycling (ND2 and RSD2). The results further demonstrate that body weights in the normal diet and corresponding resistant starch diet groups (ND0 versus RSD0 and ND2 versus RSD2) tracked closely with one another throughout the study. Final body weights differed slightly between the ND0 and RSD0 groups (7.3 g = 1.7% difference in mean final body weights), and the ND2 and RSD2 groups (8.6 g = 2.5% difference in mean final body weights). Final body weights differed more substantially between the ND1 and RSD1 groups (20.1 g = 5.1% difference in mean final body weights). Despite random assignment of rats to the six treatment groups and virtually identical mean group body weights subsequent to random assignment to groups (see Figure 1, Day 0), the body weights of the latter two groups did not track as closely as the other groups described above (see Figure 1).
Bone mineral density & content
Figure 2 contains the results for BMD and BMC for right femurs of the rats. Results are provided for the BMD and BMC of the entire femur, as well as for the distal femur and femoral neck, for a total of six variables. Pairwise comparisons in Figure 2 reveal that the values for BMD and BMC were always higher (total of 18 pairwise comparisons) in rats fed the diets containing resistant starch than in the corresponding rats fed the normal diets without added resistant starch (ND0 versus RSD0, ND1 versus RSD1, ND2 versus RSD2). Mean values for BMD-total in the RSD0, RSD1, and RSD2 groups were 3.4%, 2.0%, and 8.2% higher, respectively, than those of corresponding rats in the ND0, ND1, and ND2 groups. Values were similarly higher for BMD-femoral neck (7.1%, 6.8%, and 18.2%) and BMD-distal femur (7.2%, 6.4%, and 9.0%) in the RSD groups than the corresponding ND groups. The same pattern was observed for percentage differences in BMC between the RSD versus ND groups. The above results show that BMD and BMC were consistently higher in rats fed the resistant starch diets than in their counterparts fed the control diets; this result cannot be explained by differences in body weights between rats fed the resistant starch diets and their counterparts fed the normal diets because their body weights were very similar throughout the study (Figure 1).
Pearson correlation coefficients for the associations between BMD-total, BMD-femoral neck, and BMD-distal femur and the corresponding values for BMC were 0.818, 0.974, and 0.875 (n = 83–84, p < 0.0001).
We evaluated the results for BMD and BMC using 2-way ANOVA (Table 3) to determine the independent effects of diet (RS2 versus ND diet) and weight cycling protocol (0, 1, or 2 rounds of weight cycling), as well as the effect of diet/weight cycling interactions, on these variables. Compared to rats fed the normal diet, rats fed the RS2 diet had significantly higher BMD-total, BMD-distal femur, and BMD-femoral neck; the corresponding values for BMC were also significantly higher in RS2 -fed rats. Rats undergoing weight cycling had significantly lower BMC-total than rats not undergoing weight cycling. Weight cycling did not significantly affect the other 5 measures of BMD and BMC, although the effect of weight cycling on BMD-total approached statistical significance (p = 0.09). Weight cycling and diet did not interact to significantly influence any measure of BMD or BMC.
Figure 1 shows that rats in the four treatment groups undergoing weight cycling (ND1, ND2, RSD1, RSD2) had mean body weights that at their minimum values were about 80–120 g lower than those of rats not undergoing weight cycling (groups ND0 and RSD0). Rats undergoing weight cycling also had substantially lower final body weights. As expected, final body weights were significantly associated with BMD-total (r = 0.32, p = 0.003) and with BMC-total (r = 0.46, p < 0.0001). Therefore, to further define relationships among BMD, final body weight, and treatment group, we conducted a multiple regression analysis. In this model BMD-total was the dependent variable and final body weight and treatment group were the independent variables. Final body weight and treatment group were significant (p < 0.01) predictors of BMD-total, accounting for 18.7% of the variability in BMD-total (final body weight = 10.3% of variability, treatment group = 8.3% of variability).
None of the kidney metal concentrations measured differed significantly among treatment groups. For liver there were some differences in concentrations among treatment groups, but no consistent relationships to weight cycling or diet composition were observed.
Table 4 contains mineral concentrations for femur and lumbar vertebrae bone samples. We evaluated these results for femur mineral concentrations using 2-way ANOVA (Table 5) to determine the independent effects of diet (RS2 versus ND diet) and weight cycling protocol (0, 1, or 2 rounds of weight cycling), as well as diet/weight cycling interactions, on these variables. Compared to controls fed the normal diet, rats fed the RS2 diet had significantly higher femur calcium and magnesium concentrations, but did not have higher femur concentrations of copper, iron, manganese, and zinc. Weight cycling had no significant effect on femur metal concentrations of calcium, copper, manganese, and magnesium. However, rats undergoing weight cycling had significantly lower femur zinc, and there were significant interactions between weight cycling and diet that influenced femur iron and zinc concentrations.
Compared to controls fed the normal diet, data evaluation using 2-way ANOVA demonstrated that rats fed the RS2 diet had significantly higher lumbar vertebrae calcium and magnesium concentrations, but did not have higher concentrations of copper, iron, manganese, and zinc (Table 6); these results are consistent with the results for the femur metal concentrations. Weight cycling did not significantly affect any of the 6 lumbar vertebrae metal concentrations measured; however, as observed for the femur, there was a significant interaction between weight cycling and diet that influenced lumbar vertebrae iron concentrations.
Femur calcium, magnesium, and zinc concentrations were significantly associated with BMD-total (r = 0.24, 0.29, and 0.23, p < 0.05), but femur copper, iron, and manganese were not (r = 0.04, 0.00, and 0.01, p > 0.05). Similarly, femur calcium, magnesium, and zinc concentrations were significantly associated with BMC-total (r = 0.28, 0.30, and 0.25, p < 0.05), but femur copper, iron, and manganese were not (r = 0.02, 0.00, and 0.01, p > 0.05).
Using the femur calcium concentrations and femur weights, we calculated the total calcium content of the right femurs. These values were significantly associated with BMC-total of the right femur (r = 0.943, p < 0.0001), demonstrating very good agreement between the DEXA measurements of BMC-total done in the laboratory of one of the co-authors (SAS) and femur calcium concentrations measured by flame atomic absorption spectrophotometry in the laboratory of another co-author (JDB).
The results provide the first evidence that a dietary component, in this case RS2, can prevent or reduce loss of BMD and BMC due to weight cycling. Rats fed RS2 also had higher bone mass in the absence of weight cycling. Although the differences we found among treatment groups in BMD and BMC are small-to-moderate in magnitude (2.8–18.2%), they are within the range of the decreases in BMD and BMC of about 10% that are associated in women with a substantially increased risk of fractures of the hip, wrist, or spinal column [29, 30].
Although BMD and BMC for the total femur, distal femur, and femoral neck were consistently lower in rats undergoing weight cycling in comparison to those animals not losing weight, the differences were significant (p < 0.05) only for BMC total. Because we measured BMD and BMC only after regain of body weight, larger reductions in BMD and BMC with weight loss may have been partially restored by the rapid regain of body weight prior to harvesting the femurs for determination of BMD and BMC.
In the current study rats fed the RS2 diet had significantly higher femur calcium and magnesium concentrations. We also found significant pairwise associations between femur BMD or BMC and femur calcium and magnesium concentrations. These data suggest that dietary RS2 may prevent loss of bone mass during weight cycling by enhancing absorption and retention of calcium and/or magnesium (as suggested by the Table 5 data for femur calcium and magnesium), but not the retention of copper, iron, manganese, and zinc. This result is consistent with the results of prior studies [16, 20] showing that RS2 increases calcium and magnesium absorption; a potential mechanism for this effect is hypothesized to be the cecal wall hypertrophy and cecal acidification that RS2-induced fermentation produces in the large intestine .
Lobo et al.  have studied the effect of a diet containing 5% fructooligosaccharides (FOS) on intestinal absorption of calcium and magnesium, bone mineral density, and bone strength parameters in growing 4-week old male rats. Compared to controls, rats fed ad lib with FOS had a higher apparent absorption of calcium and magnesium, higher femur and tibia calcium concentrations, and increased femur peak load and yield load. Thus, our study and that of Lobo et al. suggest that specific dietary carbohydrates may have important roles in building and maintaining bone mass and strength during weight cycling or growth, and that the mechanism for this effect may be enhanced calcium and magnesium absorption and retention.
A recent study  used NHANES III data to estimate the mean intake of total resistant starch in the diets of USA residents age one year or older. The mean intake was 4.9 g/day, with a range of 3–8 g/day. The major sources of resistant starch were breads (21%), cooked cereals and pasta (19%), vegetables other than legumes (19%), bananas/plantains (14%), and legumes (9%). Legumes contained the most resistant starch per serving, as much as 8 grams. Comparison of the above intakes for an adult to the RS2 dose administered to the rats in the current study suggests that higher intakes than those found for the above USA residents studied may be needed to effect short-term improvements in BMD and BMC. However, it is possible that long-term consumption of intakes at the high end of the range of 3–8 g of total resistant starch daily may improve BMD and BMC.
In the current study 20-week old female rats were fed diets that were deficient in calcium but that contained levels of copper, iron, magnesium, manganese, and zinc that were near AIN-76 target values. Thus, the diets contained normal/adequate concentrations of the latter five essential metals that are considered to be important for bone health. The effects of RS2 on BMD and BMC might differ from the results found in the current study if the diets were adequate in calcium or deficient in copper, iron, magnesium, manganese, and/or zinc. The results might also differ if male rats or female rats of a different age were studied, because age and gender have substantial effects on BMD and BMC and on bone metabolism.
Weight cycling reduces bone mass. However, a diet high in RS2 can prevent or reduce loss of bone mass during weight cycling and may increase bone mass in the absence of weight cycling. The results provide the first evidence that a dietary component can help preserve BMD and BMC during weight cycling. If the above effects of dietary RS2 are found to apply to humans, then increased dietary RS2 may help to build and preserve BMD and BMC in men and women, especially during weight cycling.
Shapses SA, Reidt CS: Bone, body weight, and weight reduction: What are the concerns? J Nutr 2006, 136: 1453-1456.
Meyer HE, Tverdal A, Selmer R: Weight variability, weight change and the incidence of hip fracture: a prospective study of 39,000 middle-aged Norwegians. Osteoporosis International 1998, 8: 373-378. 10.1007/s001980050077
Fogelholm M, Sievanen H, Heinonen A, Virtanen M, Uusi-Rasi K, Pasanen M, Vuori I: Association between weight cycling history and bone mineral density in premenopausal women. Osteoporosis International 1997, 7: 354-358. 10.1007/BF01623777
Sogaard AJ, Meyer HE, Tonstad S, Haheim LL, Holme I: Weight cycling and risk of forearm fractures: a 28-year follow-up of men in the Oslo study. Am J Epidemiol 2008, 167: 1005-1013. 10.1093/aje/kwm384
Bacon L, Stern JS, Keim NL, Van Loan MD: Low bone mass in premenopausal chronic dieting obese women. Europ J Clin Nutr 2004, 58: 966-971. 10.1038/sj.ejcn.1601922
Prouteau S, Pelle A, Collomp K, Benhamou L, Courteix D: Bone density in elite judoists and effects of weight cycling on bone metabolic balance. Med Science Sports Exer 2006, 38: 694-700. 10.1249/01.mss.0000210207.55941.fb
Gallagher KI, Jakicic JM, Kiel DP, Page ML, Ferguson ES, Marcus BH: Impact of weight-cycling history on bone density in obese women. Obesity Res 2002, 10: 896-902. 10.1038/oby.2002.123
Institute of Medicine of the National Academies: Dietary Reference Intakes For Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC, National Academies Press; 2005:340-347.
Englyst HN, Kingman SM, Cummings JH: Classification and measurement of nutritionally important starch fractions. Europ J Clin Nutr 1992,46(Suppl 2):S33-S50.
Brown IL, McNaught KJ, Moloney E: Hi-maize: new directions in starch technology and nutrition. Food Australia 1995, 47: 272-275.
Brown IL, Yotsuzuka M, Birkett A, Henriksson A: Prebiotics, synbiotics and resistant starch. J Japanese Assoc Dietary Fiber Res 2006, 10: 1-9.
Younes H, Demigne C, Remesy C: Acidic fermentation in the caecum increases absorption of calcium and magnesium in the large intestine of the rat. Brit J Nutr 1996, 75: 301-314. 10.1079/BJN19960132
Morias MB, Feste A, Miller RG, Lifshitz CH: Effect of resistant and digestible starch on intestinal absorption of calcium, iron, and zinc in infant pigs. Pediatric Research 1996, 39: 872-876. 10.1203/00006450-199605000-00022
Lopez HW, Coudray C, Bellanger J, Younes H, Demigne C, Remesy C: Intestinal fermentation lessens the inhibitory effects of phytic acid on mineral utilization in rats. J Nutr 1998, 128: 1192-1198.
Lopez HW, Coudray C, Bellanger J, Levrat-Verny MA, Demigne C, Rayssiguier Y, Remesy C: Resistant starch improves mineral assimilation in rats adapted to a wheat bran diet. Nutr Research 2000, 20: 141-155. 10.1016/S0271-5317(99)00146-3
Younes H, Coudray C, Bellanger J, Demigne C, Rayssiguier Y, Remesy C: Effects of two fermentable carbohydrates (inulin and resistant starch) and their combination on calcium and magnesium balance in rats. Brit J Nutr 2001, 86: 479-485. 10.1079/BJN2001430
Lopez H, Levrat-Verny MA, Coudray C, Besson C, Krespina V, AMessager A, Demigne C, Remesy C: Class 2 resistant starches lower plasma and liver lipids and improve mineral retention in rats. J Nutr 2001, 131: 1283-1289.
Yonekura L, Tamura H, Suzuki H: Chitosan and resistant starch restore zinc bioavailability, suppressed by dietary phytate, through different mechanisms in marginally zinc-deficient rats. Nutr Research 2003, 23: 933-944. 10.1016/S0271-5317(03)00086-1
Coudray C, Demigner C, Rayssiguier Y: Effects of dietary fiber on magnesium absorption in animals and humans. J Nutr 2003, 133: 1-4.
Han S, Qiao X, Simpson S, Ameri P, Kemp FW, Bogden JD: Weight loss alters organ concentrations and contents of lead and some essential divalent metals in rats previously exposed to lead. J Nutr 1996, 126: 317-323.
Han S, Li W, Jamil U, Dargan K, Orefice M, Kemp FW, Bogden JD: Effects of weight loss and exercise on the distribution of lead and essential trace elements in rats with prior lead exposure. Environ Health Perspect 1999, 107: 657-662. 10.2307/3434458
Han S, Wang C, Li W, Tiber D, Sepulveda D, Holmes J, Kemp FW, Bogden JD: Effects of weight loss and exercise on blood and organ lead concentrations and bone density. Environ Health Perspect 1999,107(8):657-662. 10.2307/3434458
Kemp FW, Han S, Li W, Tiber D, Wang C, Sepulveda D, Holmes J, Bogden JD: Effects of weight loss and weight-bearing exercise on blood and organ concentrations of lead and some essential metals. In Trace Elements in Man and Animals. Tenth edition. Edited by: Roussel AM, Anderson RA, Favier AE. New York: Plenum Publishers; 2000:407-408.
Talbott SM, Rothkopf MM, Shapses SA: Dietary restriction of energy and calcium alters bone turnover and density in younger and older female rats. J Nutr 1998, 128: 640-645.
Heaney RP: Trace element and mineral nutrition in skeletal health and disease. In Clinical Nutrition of the Essential Trace Elements and Minerals. Totowa, NJ: Humana Press; 2000:239-249.
Ervin RB, Kennedy-Stephenson J: Mineral intakes of elderly adult supplement and non-supplement users in the Third National Health and Nutrition Examination Survey. J Nutr 2002, 132: 3422-3427.
Riedt CS, Cifuentes M, Stahl T, Chowdhury HA, Schussel Y, Shapses SA: Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake. J Bone Mineral Res 2005, 20: 455-463. 10.1359/JBMR.041132
Binkley N, Dahl DB, Engelke J, Kawahara-Baccus T, Krueger D, Colman RJ: Bone loss detection in rats using a mouse densitometer. J Bone Miner Res 2003, 18: 370-375. 10.1359/jbmr.2003.18.2.370
Divittorio G, Jackson KL, Chindalore VL, Welker W, Walker JB: Examining the relationship between bone mineral density and fracture risk reduction during pharmacologic treatment of osteoporosis. Pharmacotherapy 2006, 26: 104-114. 10.1592/phco.2006.26.1.104
Vescini F, Francucci CM, Buffa A, Stefoni S, Caudarella R: Does bone mineral density predict fractures comparably in women and men? J Endocrinol Invest 2005,28(Suppl 10):48-51.
Lobo AR, Colli C, Filisetti T: Fructooligosaccharides improve bone mass and biomechanical properties in rats. Nutr Res 2006, 26: 413-420. 10.1016/j.nutres.2006.06.019
Murphy MM, Douglas JS, Birkett A: Resistant starch intakes in the United States. J Amer Diet Assoc 2008, 108: 67-78. 10.1016/j.jada.2007.10.012
Supported in part by the National Starch and Chemical Company, Bridgewater, NJ (JDB), and by New Jersey Agricultural Experiment Station grant # 0153866 (SAS). Ms. Bernice Raveche, Ms. Sabrina Jung, and Mr. Craig Lark contributed to the laboratory work done for this project.
Drs. Birkett and Brown were employees of the National Starch and Chemical Company for a portion of the period during which this research was being done. Neither is currently employed by the company.
JDB designed and secured funding for this study, performed some of the laboratory work, and prepared the manuscript. FWK did some of the laboratory work and performed most of the data quality control efforts and statistical analyses. AEH, HA-S, and SJ did a considerable portion of the laboratory work. SAS, ILB, and AMB contributed to study design modifications, data evaluation, and manuscript revision.